A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Teva Investigational Site 31106, Barcelona

Teva Investigational Site 12963, New York

Teva Investigational Site 30107, Orbassano

Teva Investigational Site 32510, Berlin

Teva Investigational Site 30108, Genova

Teva Investigational Site 32516, Rostock

Teva Investigational Site 31104, Donostia / San Sebastian

Teva Investigational Site 32514, Hamburg

Teva Investigational Site 30102, Milan

Teva Investigational Site 30105, Gallarate

Teva Investigational Site 31111, Lleida

Teva Investigational Site 31112, Madrid

Teva Investigational Site 12971, Charlotte

Teva Investigational Site 31192, Madrid

Teva Investigational Site 31101, Málaga

Teva Investigational Site 31105, El Palmar

Teva Investigational Site 32507, Hanover

Teva Investigational Site 30103, Padua

Teva Investigational Site 32543, Goettigen

Teva Investigational Site 32517, Düsseldorf

Teva Investigational Site 31102, Seville

Teva Investigational Site 58152, Lutsk

Teva Investigational Site 12976, Columbus

Teva Investigational Site 12970, Uniontown

Teva Investigational Site 32522, Bochum

Teva Investigational Site 31100, Valencia

Teva Investigational Site 58158, Dnipropetrovsk

Teva Investigational Site 30110, Florence

Teva Investigational Site 32523, Trier

Teva Investigational Site 12977, Golden Valley

Teva Investigational Site 13010, Golden Valley

Teva Investigational Site 12973, Northbrook

Teva Investigational Site 58157, Kharkiv

Teva Investigational Site 12965, Chesterfield

Teva Investigational Site 12968, St Louis

Teva Investigational Site 12969, Lenexa

Teva Investigational Site 58150, Zaporizhzhya

Teva Investigational Site 58156, Zaporizhzhia

Teva Investigational Site 58151, Zaporizhzhya

Teva Investigational Site 58159, Ivano-Frankivsk

Teva Investigational Site 58154, Lviv

Teva Investigational Site 58153, Lviv

Teva Investigational Site 12964, Aurora

Teva Investigational Site 32513, München

Teva Investigational Site 12966, Phoenix

Teva Investigational Site 32503, Ulm

Teva Investigational Site 30106, Cefalù

Teva Investigational Site 12967, Newport Beach

Teva Investigational Site 12962, San Francisco

Teva Investigational Site 32512, Bamberg

Teva Investigational Site 32511, Würzburg

Teva Investigational Site 32505, Bad Mergentheim

Teva Investigational Site 50287, Moscow

Teva Investigational Site 50289, Saint Petersburg

Teva Investigational Site 50293, Saint Petersburg

Teva Investigational Site 50285, Kaluga

Teva Investigational Site 50288, Kazan'

Teva Investigational Site 50290, Kazan'

Teva Investigational Site 50291, Nizhny Novgorod

Teva Investigational Site 50294, Kirov

Teva Investigational Site 50295, Perm

Teva Investigational Site 50286, Novosibirsk

Teva Investigational Site 50292, Krasnoyarsk

Teva Investigational Site 12975, Kansas City

Teva Investigational Site 11089, Calgary

Teva Investigational Site 11084, Halifax

Teva Investigational Site 11081, Ottawa

Teva Investigational Site 11087, Toronto

Teva Investigational Site 11082, Montreal

Teva Investigational Site 11088, Québec

Teva Investigational Site 32509, Dresden

Teva Investigational Site 32504, München

Teva Investigational Site 30101, Rome

Teva Investigational Site 30104, Rome

Teva Investigational Site 38068, Amsterdam

Teva Investigational Site 38067, Nijmegen

Teva Investigational Site 38069, Sittard

Teva Investigational Site 53262, Bialystok

Teva Investigational Site 53250, Bydgoszcz

Teva Investigational Site 53253, Gdansk

Teva Investigational Site 53257, Katowice

Teva Investigational Site 53258, Katowice

Teva Investigational Site 53256, Katowice

Teva Investigational Site 53255, Kielce

Teva Investigational Site 53260, Lublin

Teva Investigational Site 53261, Olsztyn

Teva Investigational Site 53252, Warsaw

Teva Investigational Site 31108, Barcelona

Teva Investigational Site 58160, Kyiv

Teva Investigational Site 34190, Bristol

Teva Investigational Site 34188, Edinburgh

Teva Investigational Site 34189, Exeter

Teva Investigational Site 34182, Liverpool

Teva Investigational Site 34181, London

Teva Investigational Site 34183, Nottingham

Teva Investigational Site 34184, Oxford

Teva Investigational Site 34186, Plymouth

Teva Investigational Site 34185, Stoke-on-Trent

Teva Investigational Site 34187, Swansea